Godavari Drugs posts net profit of ₹1.26 crore in Q4FY22, 1.47% down YoY

The company has posted a consolidated Net Profit of ₹5.245 crore in the financial year ended on March 31, 2022 as against ₹4.128 crore for the financial year ended on March 31, 2021. The PAT surges up by 27.07%.

Market Times - market news
article continues after this advertisement

Godavari Drugs Limited is in the business of Contract Manufacturing, Loan License Manufacturing, Manufacturing and Supply of API, drug intermediaries and fine chemicals, capable of catering to the quality standards and requirements of the Global Life Science Industry. The company posted its Q4FY22 and year ended financial result today, the details are follows :

(I) Un Audited Consolidated Financial Results for Quarter Ended (YoY comparison):

The company has reported, a consolidated Total Income of ₹44.39 crore in the quarter ended on March 31, 2022 as against ₹33.07 crore in the corresponding quarter ended last year on Mar 31, 2021, increased by 34.24%.

The company has posted a consolidated Net Profit of ₹1.26 crore in the quarter ended on March 31, 2022 as against ₹1.28 crore in the corresponding quarter ended in last year on Mar 31, 2021. The PAT surges down by 1.47%.

The status of the EPS of the company stood at ₹1.68 as on March 31, 2022 compared to the previous quarter ended on Mar 31, 2021 which was ₹1.71, down by 1.75%.

₹*Mar 31, 2022Dec 31, 21Mar 31, 21
Total Income44.3933.8133.07
Total Expenses42.6132.3331.57
Total Tax /(credit)(0.51)(0.13)(0.2)
PAT /(Loss)1.261.331.28
*figures are in Crores

(II) Un Audited Consolidated Financial Result details for the Year Ended :

The company has reported, a consolidated Total Income of ₹161.38 crore in the financial year ended on March 31, 2022 as against ₹123.37 crore for the financial year ended on Mar 31, 2021, increased by 31.12%.

The company has posted a consolidated Net Profit of ₹5.245 crore in the financial year ended on March 31, 2022 as against ₹4.128 crore for the financial year ended on March 31, 2021. The PAT surges up by 27.07%.

The status of the EPS of the company stood at ₹6.97 as on March 31, 2022 compared to the previous year ended on March 31, 2021 which was ₹5.48, up by 27.19%.

₹*Mar 31, 2022 (FY22)Mar 31, 2021 (FY21)
Total Income161.38123.08
Total Expenses154.36117.37
Total Tax /(credit)(1.77)(1.57)
PAT /(Loss)5.2454.128
*figures are in Crores

Shares of Godavari Drugs Ltd was last traded in BSE at ₹71.15 as compared to the previous close of ₹70.60. The total number of shares traded during the day was 10370 in over 141 trades.

The stock last hit in BSE,

  • Intraday High of ₹ 73.90
  • Intraday low of ₹ 70.40